Glenmark Pharmaceuticals informs about media release

23 Dec 2020 Evaluate

Glenmark Pharmaceuticals has informed that the company has attached media release on 23rd December 2020, titled ‘Glenmark Pharmaceuticals and Menarini enter into Exclusive Licensing Agreement for commercializing Ryaltris™ Nasal Spray across numerous markets throughout Europe’ which is self explanatory.

The above information is a part of company’s filings submitted to BSE.


Glenmark Pharma Share Price

1982.00 -10.70 (-0.54%)
29-Jan-2026 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1589.30
Dr. Reddys Lab 1208.55
Cipla 1320.35
Zydus Lifesciences 890.20
Lupin 2122.65
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×